Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Fentanyl intranasal spray - Kyowa Kirin International

Next Previous
X
Search
Drug Profile

Fentanyl intranasal spray - Kyowa Kirin International

Alternative Names: Fentanyl; Fentanyl pectin; Fentanyl pectin nasal spray; FPNS; Lazanda; Nasalfent; PecFent

Latest Information Update: 05 Nov 2023

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator West Pharmaceutical Services
  • Developer AstraZeneca; Kyowa Kirin International; ProStrakan
  • Class Amides; Benzene derivatives; General anaesthetics; Opioid analgesics; Piperidines; Small molecules
  • Mechanism of Action Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Marketed Cancer pain
  • No development reported Anaesthesia

Most Recent Events

  • 02 Aug 2023 Kyowa Kirin enters deal to enter into a joint venture with Grunenthal for Fentanyl intranasal spray (PecFent®) for cancer pain
  • 28 May 2019 No recent reports of development identified for phase-I development in Anaesthesia(Adjuvant therapy) in USA (Intranasal, Spray)
  • 01 Mar 2018 Fentanyl intranasal spray is licensed to Slan Medicinal Holdings in Canada and USA

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top